LAMBDAVISION INCORPORATED
Farmington, CT · Medtech · Private
Artificial retina biodevice manufactured via layer-by-layer assembly of bacteriorhodopsin protein films, produced in microgravity for improved optical properties.
lambdavision.com →- Grants
- $2.3M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $5.4M
- 4 awards · NASA
- #117 of 4531 in medtech
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Development of a Protein-Based Retinal Implant | $149,949 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Design and Optimization of a Biocompatible Protein-Based Retinal Implant for the Treatment of End-Stage Retinal Degeneration | $1,047,071 | |
| Federal contract | National Aeronautics and Space Administration · Optimization Of The Manufacturing Parameters For The Assembly Of Protein-based Retinal Implants In Microgravity | $121,614 | |
| Federal contract· 1 of 2 same day | National Aeronautics and Space Administration · Implementation Of A Layer-by-layer Manufacturing Apparatus For The Assembly Of Protein-based Retinal Implants In Low Earth Orbit | $1,134,530 | |
| Federal grant· 2 of 2 same day | National Aeronautics and Space Administration · Phase II · Implementation of a Layer-by-Layer Manufacturing Apparatus for the Assembly of Protein-Based Retinal Implants in Low Earth Orbit | $749,530 | |
| Federal grant | National Aeronautics and Space Administration · Phase I · Feasibility study for an automated Machine Learning analytics platform for better process control of artificial retina in-space manufacturing | $156,479 | |
| Federal grant | National Aeronautics and Space Administration · Phase I · On-Orbit Solution Recycling Methods to Improve Scale of Layer-by-Layer Artificial Retina Manufacturing | $149,969 | |
| Federal contract | National Aeronautics and Space Administration · Phase II - On-orbit Solution Recycling Methods To Improve Scale Of Layer-by-layer Artificial Retina Manufacturing | $899,973 | |
| Federal contract | National Aeronautics and Space Administration · FY25 SBIR Phase III - In Space Production Of Protein- Based Artificial Retinas | $3,275,000 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 114 | Inscopix, Inc. | $5.6M | — |
| 115 | AKONNI BIOSYSTEMS INC | $5.5M | $23M |
| 116 | 410 MEDICAL, INC. | $5.5M | $29M |
| 117 | LAMBDAVISION INCORPORATED | $5.4M | — |
| 118 | MOTION CONTROL, INC | $5.4M | — |
| 119 | VIA THERAPEUTICS, LLC | $5.4M | — |
| 120 | KERICURE INC. | $5.3M | $310K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- A Method For Stimulating Retinal Cells And Treating Vision Lossgranted
- A Method For Stimulating Retinal Cells And Treating Vision Lossapplication
- Method For Stimulating Retinal Cells And Treating Vision Lossapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.